company background image
VEXT logo

Vext Science CNSX:VEXT Voorraadrapport

Laatste prijs

CA$0.18

Marktkapitalisatie

CA$45.8m

7D

2.8%

1Y

-37.3%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Vext Science, Inc.

CNSX:VEXT Voorraadrapport

Marktkapitalisatie: CA$45.8m

VEXT Overzicht aandelen

Vext Science, Inc. is via haar dochterondernemingen actief als een geïntegreerd bedrijf voor landbouwtechnologie, diensten en vastgoedbeheer in de cannabisindustrie in de Verenigde Staten.

Over het bedrijf

Beloningen

Trading at 95.1% below our estimate of its fair value
Earnings are forecast to grow 111.11% per year

Risicoanalyse

Does not have a meaningful market cap (CA$46M)
Shareholders have been diluted in the past year

Vext Science, Inc. Concurrenten

4Front Ventures

CNSX:FFNT

CA$54.9m

Simply Solventless Concentrates

TSXV:HASH

CA$55.1m

C21 Investments

CNSX:CXXI

CA$36.0m

Acreage Holdings

CNSX:ACRG.A.U

US$26.7m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Vext Science
Historische aandelenkoersen
Huidige aandelenkoersCA$0.18
52 Week HoogtepuntCA$0.42
52 Week LaagCA$0.18
Bèta1.72
11 maand verandering-15.91%
3 maanden verandering-30.19%
1 Jaar Verandering-37.29%
33 jaar verandering-77.98%
5 jaar verandering-69.17%
Verandering sinds IPO-86.79%

Recent nieuws en updates

It's Down 26% But Vext Science, Inc. (CSE:VEXT) Could Be Riskier Than It Looks

Oct 24
It's Down 26% But Vext Science, Inc. (CSE:VEXT) Could Be Riskier Than It Looks

Recent updates

It's Down 26% But Vext Science, Inc. (CSE:VEXT) Could Be Riskier Than It Looks

Oct 24
It's Down 26% But Vext Science, Inc. (CSE:VEXT) Could Be Riskier Than It Looks

Take Care Before Jumping Onto Vext Science, Inc. (CSE:VEXT) Even Though It's 30% Cheaper

Jun 18
Take Care Before Jumping Onto Vext Science, Inc. (CSE:VEXT) Even Though It's 30% Cheaper

There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Jan 16
There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Sep 29
Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Aug 16
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Jan 17
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

Dec 09
Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Sep 29
We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Apr 29
Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Nov 15
Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Is Vext Science (CSE:VEXT) A Risky Investment?

Jul 15
Is Vext Science (CSE:VEXT) A Risky Investment?

Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Apr 25
Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Based On Its ROE, Is Vext Science, Inc. (CSE:VEXT) A High Quality Stock?

Jan 15
Based On Its ROE, Is Vext Science, Inc. (CSE:VEXT) A High Quality Stock?

Rendement voor aandeelhouders

VEXTCA PharmaceuticalsCA Markt
7D2.8%-4.7%-1.5%
1Y-37.3%17.0%21.1%

Rendement versus industrie: VEXT underperformed the Canadian Pharmaceuticals industry which returned 17% over the past year.

Rendement versus markt: VEXT underperformed the Canadian Market which returned 21.1% over the past year.

Prijsvolatiliteit

Is VEXT's price volatile compared to industry and market?
VEXT volatility
VEXT Average Weekly Movement10.2%
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement8.3%
10% most volatile stocks in CA Market17.5%
10% least volatile stocks in CA Market2.9%

Stabiele aandelenkoers: VEXT has not had significant price volatility in the past 3 months compared to the Canadian market.

Volatiliteit in de loop van de tijd: VEXT's weekly volatility (10%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
2015n/aEric Offenbergerwww.vextscience.com

Vext Science, Inc. is via haar dochterondernemingen actief als een geïntegreerd bedrijf voor landbouwtechnologie, diensten en vastgoedbeheer in de cannabisindustrie in de Verenigde Staten. Het bedrijf bezit en beheert kweekfaciliteiten, productie-eenheden en dispensaria en houdt zich bezig met de teelt, extractie, productie en verkoop van THC- en CBD-cartridges, concentraten en eetbare producten. Het bedrijf houdt zich ook bezig met kleinhandel en distributie van cannabis THC- en hennep CBD-producten onder de merknamen Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness en Revibe.

Vext Science, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Vext Science zich tot de beurswaarde?
VEXT fundamentele statistieken
MarktkapitalisatieCA$45.77m
Inkomsten(TTM)-CA$9.68m
Inkomsten(TTM)CA$46.52m

1.0x

P/S-verhouding

-4.7x

Koers/Winstverhouding

Is VEXT overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
VEXT resultatenrekening (TTM)
InkomstenUS$33.33m
Kosten van inkomstenUS$25.78m
BrutowinstUS$7.55m
Overige uitgavenUS$14.49m
Inkomsten-US$6.93m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-0.028
Brutomarge22.67%
Nettowinstmarge-20.80%
Schuld/Eigen Vermogen Verhouding40.6%

Hoe presteerde VEXT op de lange termijn?

Bekijk historische prestaties en vergelijking